Open AccessThe role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes
Author(s) -
Monkgomotsi J Maseng,
Leabaneng Tawe,
Prisca K Thami,
Sikhulile Moyo,
Ishmael Kasvosve,
Vladimir Novitsky,
Max Essex,
Gianluca Russo,
Simani Gaseitsiwe,
Giacomo Maria Paganotti
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000029066
Subject(s) - medicine , efavirenz , nevirapine , cyp2b6 , pharmacology , toxicity , oncology , virology , human immunodeficiency virus (hiv) , cyp3a4 , antiretroviral therapy , cytochrome p450 , metabolism , viral load